Cases 51 - 60 of 73
Lupin Atlantis Holdings S.A. v. Mylan Inc. et al
as 1:2011cv03893
Plaintiff:
Lupin Atlantis Holdings S.A.
Defendant:
Mylan Inc. , Mylan Pharmaceuticals, Inc. and Ethypharm S.A.
Counter_claimant:
Mylan Pharmaceuticals, Inc. and Mylan Inc.
Counter_defendant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271
Mylan, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2011mc00196
Plaintiff:
Mylan, Inc.
Defendant:
Mylan Pharmaceuticals Inc., SmithKline Beecham Corporation, SmithKline Beecham P.L.C. and others
Movant:
Victoria E. Spataro
Cause Of Action: M 08-85 Motion to Quash
Lupin Atlantis Holdings S.A. v. Mylan Inc. et al
as 1:2011cv03861
Plaintiff:
Lupin Atlantis Holdings S.A.
Defendant:
Mylan Inc. , Mylan Pharmaceuticals, Inc. and Ethypharm S.A.
Counter_claimant:
Mylan Pharmaceuticals, Inc. and Mylan Inc.
Counter_defendant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271
Overly v. Merck, Sharp & Dohme, Corp. et al
as 1:2011cv03702
Plaintiff:
Gary Lynn Overly
Defendant:
Merck, Sharp & Dohme, Corp., Barr Pharmaceuticals, Inc., Barr Laboratories, Inc. and others
Cause Of Action: 28 U.S.C. § 1332
Shire LLC et al v. Mylan Inc. et al
as 1:2011cv02024
Plaintiff:
Shire LLC and Supernus Pharmaceuticals, Inc.
Defendant:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 145
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al
as 5:2011cv00050
Plaintiff:
Vivelle Ventures LLC , Novern Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation
Defendant:
Mylan Technologies, Inc., Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al
as 1:2011cv01187
Plaintiff:
Vivelle Ventures LLC , Noven Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation
Defendant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. , Mylan, Inc. and Mylan Technologies, Inc.
Counter_defendant:
Novartis Pharmaceuticals Corporation , Noven Pharmaceuticals, Inc. and Vivelle Ventures LLC
Cause Of Action: 35 U.S.C. § 271
Inghinglo v. UDL Laboratories, Inc. et al
as 1:2011cv00145
Plaintiff:
Angelina Inghinglo
Defendant:
Mylan Bertek Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., Mylan, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
Remillard v. Mylan Inc. et al
as 1:2010cv01434
Plaintiff:
Cherae Remillard
Defendant:
Mylan Inc. , Mylan Pharmaceuticals, Inc. , Mylan Technologies Inc. and others
Cause Of Action: 28 U.S.C. § 1441
PFizer Inc., et al v. Actavis Inc. et al
as 1:2010cv08197
Plaintiff:
PFizer Inc., , Pfizer Limited and Pfizer Ireland Pharmaceuticals
Defendant:
Actavis Inc., Actavis Pharma Manufacturing Pvt. Ltd. LLC, Amneal Pharmaceuticals LLC and others
Cause Of Action: 35 U.S.C. § 145
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
